Sharmila Rajan

629 total citations
11 papers, 179 citations indexed

About

Sharmila Rajan is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Sharmila Rajan has authored 11 papers receiving a total of 179 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Immunology. Recurrent topics in Sharmila Rajan's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Glycosylation and Glycoproteins Research (2 papers) and Protein purification and stability (2 papers). Sharmila Rajan is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Glycosylation and Glycoproteins Research (2 papers) and Protein purification and stability (2 papers). Sharmila Rajan collaborates with scholars based in United States, United Kingdom and Japan. Sharmila Rajan's co-authors include Sravanthi Cheeti, Jin Y. Jin, Nageshwar Budha, Mark J. Dresser, C. Andrew Boswell, Danielle Mandikian, Wilson Phung, Wendy Sandoval, Avinash Gill and Eugene C. Chen and has published in prestigious journals such as Journal of Pharmaceutical Sciences, Frontiers in Neurology and mAbs.

In The Last Decade

Sharmila Rajan

11 papers receiving 171 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sharmila Rajan United States 6 69 58 43 39 36 11 179
Elizabeth R. Gore United States 8 117 1.7× 133 2.3× 54 1.3× 207 5.3× 13 0.4× 9 324
Farnoosh Abbas‐Aghababazadeh United States 9 107 1.6× 19 0.3× 47 1.1× 45 1.2× 8 0.2× 20 222
Ariel M. Ley United States 7 72 1.0× 8 0.1× 40 0.9× 35 0.9× 9 0.3× 9 183
Liangang Liu United States 11 178 2.6× 21 0.4× 108 2.5× 47 1.2× 31 0.9× 33 339
Choon-Taek Lee South Korea 9 124 1.8× 33 0.6× 57 1.3× 24 0.6× 10 0.3× 20 404
Nicola Alcorn United Kingdom 4 45 0.7× 6 0.1× 22 0.5× 29 0.7× 26 0.7× 6 205
Malin Lindqvist Appell Sweden 12 113 1.6× 9 0.2× 45 1.0× 19 0.5× 15 0.4× 18 327
Patricia Esperón Uruguay 7 42 0.6× 11 0.2× 22 0.5× 7 0.2× 10 0.3× 30 162
G. Math� France 11 74 1.1× 39 0.7× 132 3.1× 119 3.1× 7 0.2× 25 319
H Grossmann Germany 9 111 1.6× 39 0.7× 40 0.9× 67 1.7× 7 0.2× 36 324

Countries citing papers authored by Sharmila Rajan

Since Specialization
Citations

This map shows the geographic impact of Sharmila Rajan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharmila Rajan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharmila Rajan more than expected).

Fields of papers citing papers by Sharmila Rajan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharmila Rajan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharmila Rajan. The network helps show where Sharmila Rajan may publish in the future.

Co-authorship network of co-authors of Sharmila Rajan

This figure shows the co-authorship network connecting the top 25 collaborators of Sharmila Rajan. A scholar is included among the top collaborators of Sharmila Rajan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharmila Rajan. Sharmila Rajan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Rajan, Sharmila, et al.. (2022). Effect of molecular size on interstitial pharmacokinetics and tissue catabolism of antibodies. mAbs. 14(1). 2085535–2085535. 10 indexed citations
3.
Kim, Michael T., et al.. (2021). In Vivo Reoxidation Kinetics of Free Thiols in Multiple Domains of IgG1 Antibodies in Rats. Journal of Pharmaceutical Sciences. 110(5). 1989–1996. 1 indexed citations
4.
Chen, Yvonne, Maciej Paluch, Julie A. Zorn, et al.. (2020). Targeted IgMs agonize ocular targets with extended vitreal exposure. mAbs. 12(1). 1818436–1818436. 3 indexed citations
5.
Hsiao, Yi-Chun, Yonglei Shang, Danielle DiCara, et al.. (2019). Immune repertoire mining for rapid affinity optimization of mouse monoclonal antibodies. mAbs. 11(4). 735–746. 13 indexed citations
6.
Lombana, T. Noelle, Sharmila Rajan, Julie A. Zorn, et al.. (2019). Production, characterization, andin vivohalf-life extension of polymeric IgA molecules in mice. mAbs. 11(6). 1122–1138. 40 indexed citations
7.
Rajan, Sharmila & B. Deivasigamani. (2018). Screening, Production and Characterization of extracellular glutaminase free L-Asparaginase producing endo-symbiontic bacteria from the gut of Mugil cephalus (Mullet fish). Asian Journal of Pharmacy and Pharmacology. 4(3). 288–292. 3 indexed citations
8.
Rajan, Sharmila, Danielle Mandikian, Amos Baruch, et al.. (2017). Preclinical pharmacokinetic characterization of an adipose tissue-targeting monoclonal antibody in obese and non-obese animals. mAbs. 9(8). 1379–1388. 4 indexed citations
9.
Sridevi, N., et al.. (2014). Development of anti-bovine IgA single chain variable fragment and its application in diagnosis of foot-and-mouth disease. European Journal of Microbiology and Immunology. 4(1). 34–44. 3 indexed citations
10.
Rajan, Sharmila, et al.. (2014). Generation and characterization of neutralizing monoclonal antibodies against baculo-expressed HPV 16 VLPs. European Journal of Microbiology and Immunology. 4(1). 56–64. 8 indexed citations
11.
Cheeti, Sravanthi, Nageshwar Budha, Sharmila Rajan, Mark J. Dresser, & Jin Y. Jin. (2012). A physiologically based pharmacokinetic (PBPK) approach to evaluate pharmacokinetics in patients with cancer. Biopharmaceutics & Drug Disposition. 34(3). 141–154. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026